Safety and tolerability of zalcitabine (ddC) in patients with AIDS or advanced AIDS-related complex in the European expanded access programme

This publication has 18 references indexed in Scilit:

• A Comparison of Zidovudine, Didanosine, Zalcitabine and No Antiretroviral Therapy in Patients with Advanced HIV Disease
  International Journal of STD & AIDS, 1995
• Combination and Monotherapy with Zidovudine and Zalcitabine in Patients with Advanced HIV Disease
  Annals of Internal Medicine, 1995
• A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1994
• Zalcitabine and didanosine
  The Lancet, 1993
• Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay
  Antimicrobial Agents and Chemotherapy, 1990
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• Circulating p24 Antigen Levels and Responses to Dideoxycytidine in Human Immunodeficiency Virus (HIV) Infections
  Annals of Internal Medicine, 1989
• Peripheral Neuropathy Associated With Acquired Immunodeficiency Syndrome
  Archives of Neurology, 1988
• PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)
  The Lancet, 1988
• The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987